Koyama S, Fukao K, Sakita T
Gan No Rinsho. 1984 Jul;30(8):912-24.
We cultured immunosuppressor T cells from gastric cancer patients using T-cell growth factor (TCGF) prepared from human tonsil or spleen. Peripheral blood lymphocytes cultured for 3-4 weeks with TCGF strongly inhibited the lymphocyte-proliferative response to alloantigen or PHA. Quantitative fluorescence measurement for immunological analysis of phenotypic characterization of the cells was made on a FACS-IV, using monoclonal antibodies (anti Leu-I, anti Leu-2a, anti Leu-3a, anti Leu-4, anti Leu-5, anti Leu-7, anti HLA-DR) and goat anti-human immunoglobulin. Immunosuppressor T cells grown in the presence of TCGF showed phenotype Leu-1+, 2a+, 3a-, 4+, 5+, 7-, HLA-DR+, human Ig-. Culture of immunosuppressor T cells activated by tumor cell antigen in vitro was successful only when the cells derived from patients with disseminated, nonresectable type of gastric carcinoma. Our findings suggest that TCGF-dependent immunosuppressor T cells are the result of a large tumor burden; this may explain the depression of in vitro or in vivo cell-mediated immune responses frequently found in such cancer patients.
我们使用从人扁桃体或脾脏制备的T细胞生长因子(TCGF)培养胃癌患者的免疫抑制性T细胞。用TCGF培养3 - 4周的外周血淋巴细胞强烈抑制对同种异体抗原或PHA的淋巴细胞增殖反应。使用单克隆抗体(抗Leu-1、抗Leu-2a、抗Leu-3a、抗Leu-4、抗Leu-5、抗Leu-7、抗HLA-DR)和山羊抗人免疫球蛋白,在FACS-IV上对细胞表型特征进行免疫分析的定量荧光测量。在TCGF存在下生长的免疫抑制性T细胞表现出Leu-1 +、2a +、3a -、4 +、5 +、7 -、HLA-DR +、人Ig - 的表型。仅当细胞来源于弥漫性、不可切除型胃癌患者时,体外由肿瘤细胞抗原激活的免疫抑制性T细胞培养才成功。我们的研究结果表明,依赖TCGF的免疫抑制性T细胞是肿瘤负荷大的结果;这可能解释了在此类癌症患者中经常发现的体外或体内细胞介导免疫反应的抑制。